For weight management, NICE has approved specific GLP-1 agonists (Saxenda, Wegovy) under defined criteria
The glucose-dependent mechanism of action results in a low intrinsic risk of hypoglycemia when used as monotherapy or with metformin, though risk increases when combined with insulin or sulfonylureas
The benefits have been real, and the biggest one for me is steady energy
& Harbison, R
(6) The study found that nonminorities were more likely to receive counseling (2.09 times), Exposure and Response Prevention (1.86 times), and to be taking medications (1.51 times) than ethnic minorities, who were twice as likely to have never taken medication
Lifestyle and Sun Exposure Excessive sun exposure, smoking, poor diet, and lack of sleep can slow down results